Torigen Pharmaceuticals –- which is in the process of developing new cancer vaccine products for pets -– has settled into a new 9,090-square-foot headquarters space in Farmington, CT as it continues its growth trajectory.
The company has grown from a one-person show — CEO Ashley Kalinauskas — to 25 full-time employees today, including a chief innovation officer, chief financial officer, quality scientists, and production technicians.
Torigen had been a member of UConn’s Technology Incubation Program at 400 Farmington Ave. since 2017.